Omeprazole Formulation Patent Found Valid and Infringed March 16, 2015 Astrazeneca Canada Inc. v. Apotex Inc., 2015 FC 322 (Barnes, J.)
LightRecycle: Federal Court upholds Decision of Registrar to Reject Application for Composite Trade-mark as “Clearly Descriptive” March 06, 2015 Product Care Association v. The Attorney General of Canada, 2015 FC 284 (J. Harrington)
Repayment of Royalties Following Supreme Court’s Decisions on Principle of Technological Neutrality and Duplicative Tariffs March 06, 2015 Rogers v. SOCAN, 2015 FC 286 (O'Reilly J.)
Application regarding bortezomib selection patent dismissed due to obviousness February 26, 2015 Janssen Inc. v. Teva Canada Limited, 2015 FC 247 (Barnes, J.)
Likelihood of Confusion Found Between a Word Mark and a Design Mark February 24, 2015 Restaurants La Pizzaiolle Inc. v Pizzaiolo Restaurants Inc., 2015 FC 240 (LeBlanc J.)
Clarification of Document Reference Requirements In NOAs February 23, 2015 Eli Lilly Canada Inc. v Mylan Pharmaceuticals UCL, 2015 FC 178 (Justice de Montigny)
Harley-Davidson awarded substantial costs in trade-mark action February 17, 2015 H-D U.S.A., LLC and Harley-Davidson Motor Company, Inc. v. Jamal Berrada, 3222381 Canada Inc., and El Baraka Inc., 2015 FC 189 (St-Louis, J.)
Identification of Common General Knowledge as Including Background Knowledge in the Patent Upheld as Finding of Fact February 16, 2015 Newco Tank v. Canada (Attorney General), 2015 FCA 47 (Ryer J.A.)
Application regarding bortezomib formulation patent dismissed due to obviousness February 16, 2015 Janssen Inc. v. Teva Canada Limited, 2015 FC 184 (Barnes, J.)
Federal Court finds invalidity and non-infringement allegations justified for formulation patent February 16, 2015 Les Laboratoires Servier et al v Apotex Inc et al, 2015 FC 108 (Roy J.)